KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Petmed Express (PETS) over the last 16 years, with Q4 2025 value amounting to $2.1 million.

  • Petmed Express' Asset Writedowns and Impairment changed N/A to $2.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.3 million, marking a year-over-year increase of 722687.65%. This contributed to the annual value of $1.2 million for FY2025, which is 27037.04% up from last year.
  • Per Petmed Express' latest filing, its Asset Writedowns and Impairment stood at $2.1 million for Q4 2025.
  • In the past 5 years, Petmed Express' Asset Writedowns and Impairment registered a high of $27.3 million during Q2 2025, and its lowest value of -$78000.0 during Q1 2023.
  • In the last 5 years, Petmed Express' Asset Writedowns and Impairment had a median value of $46000.0 in 2021 and averaged $1.8 million.
  • Per our database at Business Quant, Petmed Express' Asset Writedowns and Impairment plummeted by 22786.89% in 2023 and then surged by 1909577.46% in 2025.
  • Petmed Express' Asset Writedowns and Impairment (Quarter) stood at $46000.0 in 2021, then soared by 391.3% to $226000.0 in 2022, then tumbled by 92.48% to $17000.0 in 2023, then skyrocketed by 735.29% to $142000.0 in 2024, then soared by 1397.18% to $2.1 million in 2025.
  • Its Asset Writedowns and Impairment was $2.1 million in Q4 2025, compared to $27.3 million in Q2 2025 and $876000.0 in Q1 2025.